LF
STLN

Lee Financial’s Starling Oncology STLN Stock Holding History

Lee Financial’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-81,362
Closed -$250K – 168
2026
Q1 		$250K Hold
81,362
– – 0.04% 135
2025
Q4 		$290K Hold
81,362
– – 0.04% 119
2025
Q3 		$284K Hold
81,362
– – 0.04% 154
2025
Q2 		$167K Hold
81,362
– – 0.02% 142
2025
Q1 		$92.8K Hold
81,362
– – 0.01% 141
2024
Q4 		$25.1K Hold
81,362
– – ﹤0.01% 181
2024
Q3 		$26.6K Buy
81,362
+53,382
+191% +$22.1K ﹤0.01% 182
2024
Q2 		$12.9K Hold
27,980
– – ﹤0.01% 147
2024
Q1 		$44.2K Buy
+27,980
New +$53.2K 0.01% 143

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Lee Financial's STLN Position: Q2 2026 in Review

Lee Financial sold out of Starling Oncology (STLN) in Q2 2026, closing a stake of 81,362 shares — an estimated $250K sold.

Lee Financial first reported a position in STLN in Q1 2024 and held it in 9 quarters. The position peaked at $290K in Q4 2025. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Lee Financial reported no remaining Starling Oncology position as of Q2 2026 after selling out during the quarter.
  • Lee Financial sold 81,362 Starling Oncology shares in Q2 2026, an estimated $250K.
  • Lee Financial first reported a position in Starling Oncology in Q1 2024 and held it in 9 quarters.
  • Lee Financial's Starling Oncology position peaked at $290K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on Lee Financial's 13F filing for Q2 2026, filed 22 Jul 2026.